Key points are not available for this paper at this time.
Supplementary Figure 7. Biophysical characterization of the purified L111 antibody. A. Analysis of purified L111 antibody integrity by non-reduced (top) and reduced (bottom) capillary electrophoresis-SDS (CE-SDS) on a Perkin Elmer LabChip GXII Touch HT. The table shows the size and migration times of the non-reduced and reduced antibody samples. B. Size-exclusion chromatography high-performance liquid chromatography (SEC-HPLC) analysis of the purified L111 antibody. The table shows the percentage of monomers and high molecular weight species (HMWS). C. Cation-exchange chromatography of the purified L111 antibody. D. Deconvoluted mass spectrometry spectra of the purified L111 antibody. E and F. Analysis of Fc N-Glycan profiles and major glycans distribution by Hydrophilic interaction liquid chromatography (HILIC)-in combination with fluorescence detection (FLD). F. Table shows the percentage of each N-Glycan in the L111 antibody.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: